“The research just doesn’t support what they say the product does.”
It looks like we could soon be adding another to the growing list of great Canadian corporate flame-outs. There was Nortel
If your savings are tied up to any degree in Canadian stocks, you may want to take a look at your stock portfolio. Soon. Canada’s
My intention isn't to predict anything about the future of Valeant Pharmaceuticals (VRX). Instead the message is a reminder of how holdings in any market-cap weighted investment vehicle is impacted by the change in size of its constituents.
Canada has a new largest company, and for once it isn’t a bank. Laval, Quebec-based Valeant Pharmaceuticals surpassed the
Valeant Pharmaceuticals is trying to acquire Allergan, the maker of Botox. The tactics it's using to do so might end up killing
The announcement Tuesday that Montreal pharma firm Valeant is buying Arizona medical cosmetics company Medicis has brought